What is CAVITATION TECHS INC's earnings per share (EPS)?

CAVITATION TECHS INC (CVAT) reported diluted earnings per share of $0.00 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CAVITATION TECHS INC (CVAT) Financials

CVAT

FY2026 annual

Revenue $3K -98.5% YoY

Net Income Not reported for FY2026

EPS (Diluted) $0.00 YoY not available

Gross Profit $3K -98.2% YoY

Market Cap $10.5M as of Oct 20, 2026

Price / Sales n/m outside the range published as a multiple, on $3K revenue, FY2026

Price / Earnings n/m no net income reported

Price / Book n/m negative shareholder equity, so no book multiple, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Oct 6, 2026 Currency USD FYE June

Newest figures come from the 10-K for FY2026, filed Oct 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CVAT SEC filings page.

CAVITATION TECHS INC (CVAT) reported $3K in revenue for fiscal year 2026, down 98.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CVAT FY2026 2026-10-06

Cavitation Technologies now operates at minimal reported sales while its balance sheet shows liabilities exceeding assets by a wide margin.

The business’s operating deterioration preceded its latest balance-sheet contraction: revenue fell from $1.4M in FY2024 to $203K in FY2025, while operating cash flow moved from $172K to -$806K. That pairing indicates the setback involved both reduced activity and weaker cash conversion, not just an accounting-margin change.

FY2026 revenue was only $3K while research and development spending was $11K, so reported research spending exceeded sales. The resulting 100.0% gross margin is not a useful guide to underlying economics because it rests on an exceptionally small revenue base.

The latest current ratio was 0.1x, meaning current liabilities were far larger than current assets. Total liabilities reached $738K against total assets of $45K, leaving reported equity at -$693K and reversing the FY2025 current ratio of 3.7x.

Financial Health Signals

Financial health score not available

CAVITATION TECHS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

1/5

CAVITATION TECHS INC passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Key Financial Metrics

Export CSV

Earnings & Revenue

EPS (Diluted)

$0.00

CAVITATION TECHS INC earned $0.00 per diluted share (EPS) in Q4 2026.

Revenue

Not reported for Q4 2026.

EBITDA

Not reported for Q4 2026.

Net Income

Not reported for Q4 2026.

Cash & Balance Sheet

Cash & Debt

$17K

YoY-93.2%

QoQ-62.2%

5Y CAGR-58.4%

10Y CAGR-30.6%

CAVITATION TECHS INC held $17K in cash against $150K in long-term debt as of Q4 2026.

Shares Outstanding

324M

YoY+12.0%

QoQ+4.6%

5Y CAGR+8.0%

10Y CAGR+5.3%

CAVITATION TECHS INC had 324M shares outstanding in Q4 2026. This represents an increase of 12.0% from the same quarter a year earlier. Against the prior quarter it is up 4.6%.

Free Cash Flow

Not reported for Q4 2026.

Dividends Per Share

Not reported for Q4 2026.

Margins & Returns

None of these metrics is reported for Q4 2026.

Capital Allocation

None of these metrics is reported for Q4 2026.

CVAT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CVAT quarterly income statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$3K-98.5%	$203K-85.1%	$1.4M+214.8%	$433K-73.3%	$1.6M+190.1%	$558K-66.4%	$1.7M+52.6%	$1.1M-16.3%	$1.3M-31.3%	$1.9M+5.5%	$1.8M+267.5%	$489K-73.6%	$1.9M+47.3%	$1.3M+572.8%	$187K
Cost of Revenue	$0-100.0%	$38K-75.6%	$156K+28.9%	$121K+195.1%	$41K+105.0%	$20K-50.0%	$40K-42.0%	$69K-43.4%	$122K+25.8%	$97K-20.2%	$122K+65.9%	$73K-39.0%	$120K+285.5%	$31K-23.1%	$41K
Gross Profit	$3K-98.2%	$165K-86.3%	$1.2M+286.9%	$312K-80.2%	$1.6M+193.3%	$538K-66.9%	$1.6M+59.0%	$1.0M-13.5%	$1.2M-34.4%	$1.8M+7.4%	$1.7M+303.1%	$416K-76.0%	$1.7M+41.3%	$1.2M+737.7%	$147K
R&D Expenses	$11K-88.4%	$95K+55.7%	$61K+1933.3%	$3K-82.4%	$17K-19.0%	$21K+16.7%	$18K-28.0%	$25K0.0%	$25K-7.4%	$27K-8.1%	$29K+31.6%	$22K-45.3%	$41K-70.9%	$140K-7.7%	$152K
SG&A Expenses	N/A	$1.1M+49.3%	$708K-40.8%	$1.2M-30.8%	$1.7M+36.7%	$1.3M-14.0%	$1.5M-14.5%	$1.7M+14.1%	$1.5M-24.8%	$2.0M+65.1%	$1.2M-31.5%	$1.8M-27.5%	$2.4M+26.8%	$1.9M+12.1%	$1.7M
Operating Income	N/A	-$987K-325.3%	$438K+149.4%	-$886K-196.3%	-$299K+60.0%	-$747K-649.3%	$136K+118.8%	-$723K-106.0%	-$351K-51.3%	-$232K	N/A	N/A	-$749K+10.7%	-$840K+51.4%	-$1.7M
EBITDA	N/A	-$987K-324.8%	$439K+149.7%	-$883K-195.3%	-$299K+58.8%	-$725K-514.3%	$175K+125.7%	-$682K-127.3%	-$300K-66.7%	-$180K	N/A	N/A	-$649K+6.9%	-$697K+58.4%	-$1.7M
Interest Expense	N/A	$6K+700.0%	-$1K-116.7%	$6K+20.0%	$5K-16.7%	$6K	$0	N/A	N/A	N/A	N/A	N/A	N/A	$10K	N/A
Income Tax	$0	$0	N/A	$0	$0	$0	$0	$0	N/A	N/A	$0	N/A	$0	$0	$0
Net Income	N/A	-$113K-125.7%	$439K+121.5%	-$2.0M-229.6%	-$619K+4.6%	-$649K-607.0%	$128K+117.7%	-$723K-189.2%	-$250K-7.3%	-$233K-153.8%	$433K+131.4%	-$1.4M+36.9%	-$2.2M-121.1%	-$988K+48.8%	-$1.9M
EPS (Basic)	$0.00	$0.00	$0.00+100.0%	-$0.01	$0.00	$0.00	N/A	N/A	N/A	N/A	N/A	N/A	-$0.010.0%	-$0.01	N/A
EPS (Diluted)	$0.00	$0.00	$0.00+100.0%	-$0.01	$0.00	$0.00	N/A	N/A	N/A	N/A	N/A	N/A	-$0.01	-$0.01	N/A
Diluted Shares (Avg)	303M+6.1%	286M+0.6%	284M+0.9%	282M+13.2%	249M+26.1%	197M+0.1%	197M-0.5%	198M+0.4%	197M+1.1%	195M+0.4%	194M+6.0%	183M+14.2%	161M	160M	N/A

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Revenue	N/A	$3K-97.5%	$0-100.0%	$3K	N/A	$122K-76.5%	$76K-60.4%	$0
Cost of Revenue	N/A	$0-100.0%	$0-100.0%	N/A	N/A	$25K+257.1%	$13K-61.8%	N/A
Gross Profit	N/A	$3K-96.9%	$0-100.0%	N/A	N/A	$97K-81.1%	$63K-60.1%	N/A
R&D Expenses	N/A	N/A	$4K-75.0%	$7K-12.5%	N/A	$42K+366.7%	$16K	$8K-77.8%
SG&A Expenses	N/A	$234K-17.3%	N/A	$245K+12.4%	N/A	$283K+66.5%	$346K+101.2%	$218K+1.9%
Operating Income	N/A	-$231K-1.3%	N/A	-$249K-10.2%	N/A	-$228K-168.5%	-$299K-2035.7%	-$226K+9.6%
EBITDA	N/A	N/A	N/A	N/A	N/A	-$228K-168.5%	N/A	N/A
Interest Expense	N/A	$3K+50.0%	$2K0.0%	$9K+800.0%	N/A	$2K0.0%	$2K0.0%	$1K0.0%
Net Income	N/A	-$219K+4.8%	N/A	-$258K-13.7%	N/A	-$230K-169.5%	$579K+3718.8%	-$227K+9.6%
EPS (Basic)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
EPS (Diluted)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Diluted Shares (Avg)	N/A	310M+8.1%	301M+5.9%	289M+1.7%	N/A	286M+0.8%	284M0.0%	284M0.0%

Not reported in any period shown, so not listed: Income Tax.

CVAT Balance Sheet

CVAT quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$45K-84.8%	$297K+19.8%	$248K+73.4%	$143K-92.4%	$1.9M+2.2%	$1.8M+40.4%	$1.3M+27.7%	$1.0M-5.4%	$1.1M+16.0%	$930K-3.1%	$960K-45.5%	$1.8M+13.1%	$1.6M+160.1%	$599K+5.0%	$570K
Current Assets	$34K-88.1%	$286K+46.7%	$195K+983.3%	$18K-96.6%	$528K-62.1%	$1.4M+53.2%	$910K-3.8%	$946K-3.4%	$979K+26.0%	$777K-4.2%	$811K-49.7%	$1.6M+20.2%	$1.3M+280.7%	$353K+16.8%	$302K
Cash & Equivalents	$17K-93.2%	$249K+39.1%	$179K+894.4%	$18K-95.9%	$441K-67.6%	$1.4M+79.6%	$759K+16.9%	$649K-31.3%	$945K+72.1%	$549K-16.4%	$657K-55.6%	$1.5M+20.6%	$1.2M+406.9%	$242K+76.3%	$137K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	$0	$0-100.0%	$48K+92.0%	$25K-46.8%	$47K-17.5%	$57K+67.6%	$34K-76.2%	$143K-7.0%	$154K+13.4%	$136K+16.3%	$117K+8.3%	$108K-23.6%	$141K
Accounts Receivable	$0-100.0%	$10K	$0	$0-100.0%	$1K-83.3%	$6K-94.2%	$104K-56.7%	$240K	$0-100.0%	$85K	N/A	$0	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$738K+223.7%	$228K-68.7%	$728K-31.5%	$1.1M+27.2%	$835K-62.8%	$2.2M+25.0%	$1.8M-2.5%	$1.8M+13.3%	$1.6M+30.9%	$1.2M-22.6%	$1.6M-43.5%	$2.8M+46.3%	$1.9M-28.8%	$2.7M+7.5%	$2.5M
Current Liabilities	$588K+653.8%	$78K-87.0%	$598K-30.8%	$864K+54.8%	$558K-68.9%	$1.8M+25.3%	$1.4M-22.2%	$1.8M+13.3%	$1.6M+30.9%	$1.2M-22.6%	$1.6M-43.5%	$2.8M+46.3%	$1.9M-28.8%	$2.7M+7.5%	$2.5M
Non-Current Liabilities	$150K0.0%	$150K+15.4%	$130K-34.3%	$198K-28.5%	$277K-38.0%	$447K+23.5%	$362K	$0	$0	$0-100.0%	$225	$0	$0	$0	$0
Long-Term Debt	$150K0.0%	$150K+15.4%	$130K-10.3%	$145K-3.3%	$150K-40.9%	$254K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$693K-1104.3%	$69K+114.4%	-$480K+47.8%	-$919K-188.7%	$1.0M+352.1%	-$411K+16.1%	-$490K+40.2%	-$819K-50.3%	-$545K-75.2%	-$311K+51.6%	-$643K+40.2%	-$1.1M-181.5%	-$382K+82.0%	-$2.1M-8.3%	-$2.0M
Retained Earnings	-$28.4M-5.2%	-$27.0M-0.4%	-$26.8M+1.6%	-$27.3M-8.1%	-$25.2M-2.5%	-$24.6M-2.7%	-$24.0M+0.5%	-$24.1M-3.1%	-$23.4M-1.1%	-$23.1M-1.0%	-$22.9M+1.9%	-$23.3M-6.3%	-$22.0M-11.1%	-$19.8M-5.3%	-$18.8M

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Total Assets	$45K-84.8%	$66K-88.5%	$55K-92.3%	$60K-22.1%	$297K+19.8%	$576K+109.5%	$718K+647.9%	$77K-68.8%
Current Assets	$34K-88.1%	$55K-90.3%	$44K-93.7%	$49K+16.7%	$286K+46.7%	$565K+177.0%	$701K+9914.3%	$42K-70.0%
Cash & Equivalents	$17K-93.2%	$45K-89.6%	$31K-95.4%	$30K+1400.0%	$249K+39.1%	$432K+136.1%	$681K+9628.6%	$2K-98.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	$11K	N/A
Accounts Receivable	$0-100.0%	$3K-97.5%	$0	$5K	$10K	$122K+542.1%	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$738K+223.7%	$533K+92.4%	$303K-59.1%	$249K-68.2%	$228K-68.7%	$277K-75.5%	$741K-42.2%	$784K-44.7%
Current Liabilities	$588K+653.8%	$383K+155.3%	$153K-75.0%	$99K-84.9%	$78K-87.0%	$150K-84.8%	$613K-45.5%	$656K-47.0%
Non-Current Liabilities	$150K0.0%	$150K+18.1%	$150K+17.2%	$150K+17.2%	$150K+15.4%	$127K-12.4%	$128K-19.0%	$128K-28.5%
Long-Term Debt	$150K0.0%	$150K+18.1%	$150K+17.2%	$150K+17.2%	$150K+15.4%	$127K	$128K	$128K
Total Equity	-$693K-1104.3%	-$467K-256.2%	-$248K-978.3%	-$189K+73.3%	$69K+114.4%	$299K+135.0%	-$23K+98.1%	-$707K+39.6%
Retained Earnings	-$28.4M-5.2%	-$27.9M-4.4%	-$27.7M-4.5%	-$27.2M-0.5%	-$27.0M-0.4%	-$26.7M+1.8%	-$26.5M+3.8%	-$27.1M+1.7%

Not reported in any period shown, so not listed: Goodwill.

CVAT Cash Flow Statement

CVAT quarterly cash flow statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	N/A	-$806K-568.6%	$172K+140.7%	-$423K+12.6%	-$484K-93.6%	-$250K-546.4%	$56K+120.0%	-$280K-170.7%	$396K+861.5%	-$52K+93.2%	-$760K-654.4%	-$101K-415.5%	$32K-95.5%	$709K+769.5%	-$106K
Depreciation & Amortization	N/A	$0-100.0%	$1K-66.7%	$3K	$0-100.0%	$22K-43.6%	$39K-4.9%	$41K-19.6%	$51K-1.9%	$52K-13.5%	$60K-33.0%	$90K-10.8%	$101K-29.6%	$143K+182.8%	$51K
Stock-Based Compensation	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$449K	$0	N/A	N/A	N/A	$0-100.0%	$113K-48.9%	$222K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$128K+156.0%	$50K+212.5%	$16K	$0-100.0%	$56K-9.0%	$62K+170.6%	$23K-47.4%	-$43K-52.0%	$90K	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$378K-6400.0%	$6K+102.0%	-$296K-174.7%	$396K+466.7%	-$108K+86.8%	-$821K-565.2%	-$123K-988.2%	-$11K-101.8%	$619K	N/A
Investing Cash Flow	$0-100.0%	$880K	$0	$0+100.0%	-$1.2M-855.5%	-$128K-156.0%	-$50K-212.5%	-$16K	$0+100.0%	-$56K+9.0%	-$62K-170.6%	-$23K+67.0%	-$69K+42.9%	-$121K-125.0%	-$54K
Financing Cash Flow	N/A	-$4K+63.6%	-$11K	$0-100.0%	$785K-20.1%	$982K+844.2%	$104K	$0	N/A	N/A	$0-100.0%	$375K-63.2%	$1.0M+311.2%	-$484K-271.5%	$282K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$25K	$0

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Operating Cash Flow	N/A	-$126K+49.2%	-$182K+9.5%	-$219K-25.1%	-$182K-2700.0%	-$248K-240.9%	-$201K-51.1%	-$175K-243.4%
Depreciation & Amortization	N/A	N/A	N/A	N/A	$0	$0	N/A	N/A
Investing Cash Flow	$0	$0	N/A	N/A	$0	$0	N/A	N/A
Financing Cash Flow	$200K+20100.0%	$140K+14100.0%	$183K	$0+100.0%	-$1K+90.9%	-$1K	$0	-$2K

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

CVAT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CVAT quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	100.0%+18.7pp	81.3%-7.3pp	88.5%+16.5pp	72.1%-25.4pp	97.5%+1.1pp	96.4%-1.2pp	97.6%+3.9pp	93.7%+3.0pp	90.6%-4.2pp	94.9%+1.6pp	93.2%+8.2pp	85.0%-8.5pp	93.5%-4.0pp	97.5%+19.2pp	78.3%
Operating Margin	N/A	-486.2%	32.1%	-204.6%	-18.5%	-133.9%	8.2%+74.5pp	-66.3%-39.4pp	-26.9%-14.7pp	-12.2%	N/A	N/A	-40.4%+26.3pp	-66.6%	-921.7%
Net Margin	N/A	-55.7%-87.9pp	32.2%	-471.1%	-38.2%	-116.3%	7.7%+74.0pp	-66.3%-47.1pp	-19.2%-6.9pp	-12.3%-36.4pp	24.1%	-281.8%	-117.7%	-78.5%	-1029.9%
Return on Equity	N/A	-163.8%	N/A	N/A	-59.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-38.0%-215.1pp	177.0%+1603.6pp	-1426.6%-1393.5pp	-33.1%+2.4pp	-35.4%-45.3pp	9.8%+80.6pp	-70.8%-47.6pp	-23.2%+1.9pp	-25.1%-70.2pp	45.1%+123.4pp	-78.3%+62.0pp	-140.3%+24.8pp	-165.0%+173.0pp	-338.0%
Current Ratio	0.06-3.6x	3.67+3.3x	0.33+0.3x	0.02-0.9x	0.95+0.2x	0.78+0.1x	0.64+0.1x	0.51-0.1x	0.600.0x	0.63+0.1x	0.51-0.1x	0.57-0.1x	0.69+0.6x	0.130.0x	0.12
Debt-to-Equity	N/A	2.17	N/A	N/A	0.14	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover	0.07-0.6x	0.68-4.8x	5.50+2.5x	3.03+2.2x	0.87+0.6x	0.30-1.0x	1.28+0.2x	1.07-0.1x	1.21-0.8x	2.04+0.2x	1.87+1.6x	0.28-0.9x	1.19-0.9x	2.10+1.8x	0.33
FCF Margin	N/A	N/A	N/A	N/A	N/A	-67.7%-68.1pp	0.4%+27.5pp	-27.2%-57.6pp	30.4%+36.1pp	-5.7%+40.0pp	-45.7%-20.4pp	-25.2%-24.6pp	-0.6%-49.7pp	49.1%	N/A

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Gross Margin	N/A	100.0%+20.5pp	N/A	N/A	N/A	79.5%-19.1pp	82.9%+0.6pp	N/A
Operating Margin	N/A	-7700.0%	N/A	-8300.0%	N/A	-186.9%	-393.4%	N/A
Net Margin	N/A	-7300.0%	N/A	-8600.0%	N/A	-188.5%	761.8%	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	-76.9%	N/A	N/A
Return on Assets	N/A	-331.8%-291.9pp	N/A	-430.0%-135.2pp	N/A	-39.9%-160.3pp	80.6%+97.3pp	-294.8%-193.2pp
Current Ratio	0.06-3.6x	0.14-3.6x	0.29-0.9x	0.49+0.4x	3.67+3.3x	3.77+3.6x	1.14+1.1x	0.060.0x
Debt-to-Equity	N/A	N/A	N/A	N/A	2.17	0.42	N/A	N/A
Asset Turnover	N/A	0.05-0.2x	0.00-0.1x	0.05+0.1x	N/A	0.21-1.7x	0.11-1.9x	0.000.0x

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Note: Shareholder equity is negative (-$693K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
CAVITATION TECHS INC CVAT	FY2026	$3K	N/A	N/A	$10.5M	—
NEWHYDROGEN INC NEWH	FY2025	N/A	-$2.8M	N/A	$16.9M	—

Where CAVITATION TECHS INC Ranks

Frequently Asked Questions

What is CAVITATION TECHS INC's annual revenue?

CAVITATION TECHS INC (CVAT) reported $3K in total revenue for fiscal year 2026. This represents a -98.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CAVITATION TECHS INC's revenue growing?

CAVITATION TECHS INC (CVAT) revenue declined by 98.5% year-over-year, from $203K to $3K in fiscal year 2026.

How much debt does CAVITATION TECHS INC have?

As of fiscal year 2026, CAVITATION TECHS INC (CVAT) had $17K in cash and equivalents against $150K in long-term debt.

What is CAVITATION TECHS INC's gross margin?

CAVITATION TECHS INC (CVAT) had a gross margin of 100.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What are CAVITATION TECHS INC's total assets?

CAVITATION TECHS INC (CVAT) had $45K in total assets as of fiscal year 2026, including both current and long-term assets.

How much does CAVITATION TECHS INC spend on research and development?

CAVITATION TECHS INC (CVAT) invested $11K in research and development during fiscal year 2026.

How many shares does CAVITATION TECHS INC have outstanding?

CAVITATION TECHS INC (CVAT) had 324M shares outstanding as of fiscal year 2026.

What is CAVITATION TECHS INC's current ratio?

CAVITATION TECHS INC (CVAT) had a current ratio of 0.06 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

What is CAVITATION TECHS INC's P/E ratio?

CAVITATION TECHS INC (CVAT) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $10.5M as of Oct 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is CAVITATION TECHS INC's price-to-sales ratio?

CAVITATION TECHS INC (CVAT) has no price-to-sales ratio at the moment: outside the range published as a multiple (on $3K revenue, FY2026). The market capitalization is $10.5M as of Oct 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Why is CAVITATION TECHS INC's debt-to-equity ratio negative or not reported?

CAVITATION TECHS INC (CVAT) has negative shareholder equity of -$693K as of fiscal year 2026, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is CAVITATION TECHS INC's Piotroski F-Score?

CAVITATION TECHS INC (CVAT) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.